Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
The daily number of COVID-19 cases reported in the nation has surged over the past two weeks, now surpassing 1 million, with 95% of them from the omicron variant. At such a rate, every week, over 2% of the entire population becomes infected.
Some of the 33 million adults in the nation who remain unvaccinated against COVID-19 may believe that the vaccines are risky. Medical systems around the country have debunked myths about their risk. Whether vaccine resistance is attributed to the speed at which the vaccines were developed, reported vaccine side effects, or breakthrough infections, those who remain on the vaccine sidelines are exposing themselves to much higher risk with the virus than the vaccine itself may pose.
The worsening trend is another hurdle in the nation's supply chain crisis as the ports in LA and Long Beach attempt to rebound after a backlog caused largely by COVID-19.
CHAMPAIGN — At this point in the calendar last year, a No. 1 seed in the NCAA tournament didn’t seem likely for Illinois.
For Americans, COVID's global supply chain disruption had remained more abstraction or inconvenience than potentially life-threatening reality. But that all changed when blood, platelets and plasma were added to the roster of critically short commodities, thanks to COVID's rampaging Omicron variant.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine